Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,591.90
(
0.54%
)
US TECH 100
23,501.20
(
0.61%
)
Dow Jones
46,429.49
(
0.66%
)
Brent Oil
98.77
(
2.35%
)
Bitcoin
70,999.77
(
0.68%
)
News Focus
News Focus
Post# of 257285
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

donotknowityet

Send PM Follow Ignore
Followers 0
Posts 102
Boards Moderated 0
Alias Born 06/30/2005

donotknowityet

Re: rfj1862 post# 37713

Monday, 11/20/2006 12:58:51 AM

Monday, November 20, 2006 12:58:51 AM

Post# of 257285
John, Merch was actually quite successful with Aggrastat in the USA with about $90 mil/year sales 6 years ago. At that time they sold the USA marketing rights, and that is when the failure came.

Merck still markets Aggrastat in Europe where it is the market leader.
Now Why did they sold the USA rights? I Dunno.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today